Evidence map›Paper›PMID 24037693›Full record

ArticleMuscle & nerve2013

Screening for HIV-associated peripheral neuropathy in resource-limited settings.

Deanna Cettomai, Judith K Kwasa, Gretchen L Birbeck, Richard W Price, Craig R Cohen, Elizabeth A Bukusi, Caroline Kendi, Ana-Claire L Meyer

Registry-linked trialOpen access · greenAbstract readComparative Study
In one paragraph

Article in Muscle & nerve, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05678660 (Study of Neurological Aging Among People Living With HIV), which is not on this map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05678660 active not recruitingnot on this mapstarted 2022, after this paper: background citation

Study of Neurological Aging Among People Living With HIV (SNAP)

TypeobservationalSponsorUniversity of RochesterRan2022 to 2027Enrolled298ConditionsAging, Premature
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Neurology and the Global HIV Epidemic.Seminars in neurology · 2014
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Deanna CettomaiDepartment of Neurology, University of California San Francisco, 1001 Potrero Avenue, 4M62, Box 0870, San Francisco, California, 94110, USA.
Judith K Kwasa
Gretchen L Birbeck
Richard W Price
Craig R Cohen
Elizabeth A Bukusi
Caroline Kendi
Ana-Claire L Meyer
University of California, San Francisco · USKenya Medical Research Institute · KE

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
Treatment of HIV-Associated Cognitive ImpairmentK01TW008764 · FIC · YALE UNIVERSITY · PI MEYER, ANA-CLAIRE LEW · 2011 to 2015
$676k
FIC NIH HHS 3 R24 TW00798-02S1FIC NIH HHS 5 R24 TW00798FIC NIH HHS K01 TW008764NIAID NIH HHS P30 AI027763
6 · The paper itself

Abstract

introductionPeripheral neuropathy is the most common neurological complication of human immunodeficiency virus (HIV) infection but is widely under-diagnosed in resource-limited settings. We investigated the utility of screening tools administered by nonphysician healthcare workers (HCW) and quantitative sensory testing (QST) administered by trained individuals for identification of moderate/severe neuropathy.

methodsWe enrolled 240 HIV-infected outpatients using 2-stage cluster randomized sampling. HCWs administered the several screening tools. Trained study staff performed QST. Tools were validated against a clinical diagnosis of neuropathy.

resultsParticipants were 65% women, mean age 36.4 years, median CD4 324 cells/μL. A total of 65% were taking antiretrovirals, and 18% had moderate/severe neuropathy. The screening tests were 76% sensitive in diagnosing moderate/severe neuropathy with negative predictive values of 84-92%. QST was less sensitive but more specific.

conclusionsScreening tests administered by HCW have excellent negative predictive values and are promising tools for scale-up in resource-limited settings. QST shows promise for research use.

Indexed as

AdultAnti-Retroviral AgentsCD4 Lymphocyte CountDeveloping CountriesFemaleHealth PersonnelHIV InfectionsHumansMaleMass ScreeningMiddle AgedPeripheral Nervous System DiseasesPredictive Value of TestsRandom AllocationSensitivity and SpecificitySeverity of Illness IndexAnti-Retroviral Agentsdeveloping countriesHIVperipheral nervous system diseasesscreening toolssensitivity and specificity

Identifiers

PMID24037693
PMCPMC4019398
OpenAlexW2100009147

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.